← Retour au blog
tech 26 August 2026

FDA Authorizes First Wearable Device to Monitor Glucose and Ketones

The FDA has authorized a groundbreaking device, the Libre Duo 10 Day, capable of continuously monitoring glucose and ketone levels. A major advancement for those living with diabetes.

Article inspired by the original source
FDA authorizes first wearable device that monitors ketone and blood sugar levels ↗ www.fda.gov

A Major Technological Breakthrough for Diabetes

On August 25, 2026, the FDA authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System. This wearable device, aimed at individuals aged 2 and older living with diabetes, marks a significant innovation in managing this chronic condition. By monitoring both glucose and ketone levels, it allows for quicker detection of early warning signs of severe complications.

Why Monitoring Ketones is Critical

For the 40.1 million Americans living with diabetes, glucose monitoring is essential. However, for the 2.1 million individuals with type 1 diabetes, ketones also play a critical role. High ketone presence can lead to diabetic ketoacidosis, a potentially life-threatening emergency. The Libre Duo 10 Day provides real-time data, enabling swift and effective intervention.

Features and Benefits of the Libre Duo 10 Day

The device offers continuous monitoring over 10 days, providing users with a comprehensive view of their glucose and ketone levels. By integrating these two metrics, it reduces the need for multiple tests and enhances patients’ quality of life. Additionally, the device is designed to be non-invasive and easy to use, encouraging broader adoption.

Potential Impact on the Healthcare System

The introduction of devices like the Libre Duo 10 Day could transform diabetes management. By enabling proactive monitoring, diabetes-related hospitalizations could decrease, thus reducing costs for patients and the healthcare system. According to a recent study, the use of real-time monitoring technologies could reduce hospital admissions for diabetic ketoacidosis by 20%.

The Future of Wearable Health Devices

The Libre Duo 10 Day is just the beginning. Tech companies continue to innovate, integrating AI and machine learning to further enhance the accuracy and functionality of wearable medical devices. These innovations promise to revolutionize not only diabetes management but also other chronic diseases.

Conclusion

Continuous monitoring of glucose and ketone levels offers a new era of safety and management for individuals living with diabetes. By integrating these technologies into their daily routine, patients can hope for a healthier and more serene life. Let's discuss your project in 15 minutes.

wearable device diabetes management glucose monitoring ketone levels FDA authorization
Deepthix newsletter · 100% AI · every Monday 8am

An AI agent reads tech for you.

Our AI agent scans ~200 sources per week and ships the best articles to your inbox Monday 8am. Free. One click to unsubscribe.

Visit the newsletter page →

Want to automate your operations?

Let's talk about your project in 15 minutes.

Book a call